Skip to main content

CSW Industrials Declares Quarterly Dividend of $0.27 Per Share

DALLAS, July 11, 2025 (GLOBE NEWSWIRE) — The Board of Directors of CSW Industrials, Inc. (NYSE: CSW) today declared a regular quarterly cash dividend of $0.27 per share. The dividend is payable on August 8, 2025, to shareholders of record as of the close of business on July 25, 2025.DetailsDividend Amount: $0.27Record Date: July 25, 2025Payable Date: August 8, 2025   About CSW Industrials CSW Industrials is a diversified industrial growth company with industry-leading operations in three segments: Contractor Solutions, Specialized Reliability Solutions, and Engineered Building Solutions. CSW provides niche, value-added products with two essential commonalities: performance and reliability. The primary end markets we serve with our well-known brands include: HVAC/R, plumbing, electrical, general industrial, architecturally-specified...

Continue reading

N2OFF Completes $1.2 million of its $2.7 million Total Commitment to Finance 196MWp Battery Energy Storage Assets in Italy

According to industry sources, “Ready to Build” battery storage projects of this capacity may yield up to $13.5 million Neve Yarak, Israel, July 11, 2025 (GLOBE NEWSWIRE) — Today, N2OFF, Inc.(NASDAQ: NITO) (FSE:80W) (“N2OFF” and the “Company”), a cleantech company investing in “Agrifood” Techs Solutions and sustainable energy solutions through Solar Energy assets based on the RTB (Ready to Build ) business model, announced completion of the second installment of a $2.7 million investment for financing and supporting the development of two Battery Energy Storage Systems (“BESS”) in Sicily, Italy, each with a capacity of 98MWp/392MWh. To date, the Company has invested over $1.2 million in its 70% -owned Italian subsidiary. The Company’s BESS projects in Italy are RTB assets, aiming to secure the necessary permits, grid...

Continue reading

Sify Technologies to announce Financial Results for First Quarter FY 2025-26 on Friday, July 18, 2025

CHENNAI, India, July 11, 2025 (GLOBE NEWSWIRE) — Sify Technologies Limited (NASDAQ: SIFY), India’s leading Digital ICT solutions provider with global service capabilities spanning Data Center, Cloud, Networks, Security and Digital services, today announced that it will report its unaudited IFRS financial results for the First quarter ended June 30, 2025 on Friday, July 18, 2025 before the market opens.  In conjunction with the announcement, Sify will host a conference call at 8:30 AM ET with Mr. Raju Vegesna, Chairman of the Board and Mr. M P Vijay Kumar, Executive Director & Group CFO. Interested parties may participate by dialling +1-888-506-0062 (Toll Free in the U.S. or Canada) or +1-973-528-0011 (International), which will also be simultaneously broadcast live over the Internet at www.sifytechnologies.com/investors or...

Continue reading

NV5 Acquires Professional Systems Engineering; Strengthens Technology Design for Public Safety Facilities

HOLLYWOOD, Fla., July 11, 2025 (GLOBE NEWSWIRE) — NV5, a provider of tech-enabled engineering, certification, and consulting solutions, announced today its acquisition of Professional Systems Engineering, LLC, (PSE) a leading designer of facility technologies for corrections and public safety infrastructure throughout the Northeast. Founded in 1986, PSE’s engineers and consultants specialize in the design of security, safety, fire, and communication systems for high-security public sector facilities such as corrections, justice, healthcare, and educational facilities. “NV5 is a leader in the design of audiovisual, fire protection, security, surveillance, and intelligent building systems that employ the latest technologies to improve the safety, function, and comfort of the built environment,” said Ben Heraud, CEO of NV5. “Professional...

Continue reading

Shareholders of Renergen Limited Approve Proposed Acquisition by ASP Isotopes Inc.

WASHINGTON, July 11, 2025 (GLOBE NEWSWIRE) — ASP Isotopes Inc. NASDAQ: ASPI (“ASP Isotopes” or the “Company”), an advanced materials company dedicated to the development of technology and processes for the production of isotopes for use in multiple industries, today announced that at a general meeting of shareholders of Renergen Limited (“Renergen”) held on July 10, 2025, Renergen shareholders voted overwhelmingly in favor of the acquisition of Renergen by ASP Isotopes through a scheme of arrangement (the “Scheme”) in accordance with Sections 114 and 115 of the South African Companies Act, No. 71 of 2008. The Scheme received support from 99.80% of voting shareholders. The implementation of the Scheme remains subject to and will only become operative upon the fulfilment or, if applicable, waiver of a number of conditions,...

Continue reading

Ikena Oncology Announces ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Merger with Inmagene Biopharmaceuticals

BOSTON, July 11, 2025 (GLOBE NEWSWIRE) — Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena,” the “Company”) today announced that Institutional Shareholder Services Inc. (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”) recommend that stockholders vote FOR the issuance of shares in connection with the previously disclosed proposed merger with Inmagene Biopharmaceuticals (“Inmagene”) at Ikena’s upcoming Annual Meeting of Stockholders on July 15, 2025. ISS and Glass Lewis are leading U.S. institutional voting advisory services that regularly publish analyses on public shareholder votes. Inmagene is a privately held, clinical stage biopharmaceutical company focused on developing IMG-007, a nondepleting anti-OX40 monoclonal antibody (mAb) engineered to have a silenced antibody-dependent cellular cytotoxicity (ADCC) function to minimize potential...

Continue reading

Rogers Announces Cash Tender Offers for Eight Series of U.S. Dollar Debt Securities

TORONTO, July 11, 2025 (GLOBE NEWSWIRE) — Rogers Communications, Inc. (“Rogers” or the “Company”) (TSX: RCI.A and RCI.B; NYSE: RCI) today announced the commencement of separate offers (the “Offers”) to purchase for cash any and all of the outstanding notes of each series listed in the table below (collectively, the “Notes”), up to a maximum of US$1,250,000,000 aggregate Total Consideration (as defined below). Subject to the Consideration Cap Condition (as defined below), the series of Notes that are purchased in the Offers will be based on the acceptance priority levels (each, an “Acceptance Priority Level”) set forth in the table below. If a given series of Notes is accepted for purchase pursuant to the Offers, all Notes of that series that are validly tendered and not validly withdrawn will be accepted for purchase. No series...

Continue reading

Rogers Announces Cash Tender Offers for Six Series of Debt Securities

TORONTO, July 11, 2025 (GLOBE NEWSWIRE) — Rogers Communications Inc. (“Rogers” or the “Company”) (TSX: RCI.A and RCI.B; NYSE: RCI) today announced the commencement of separate offers (the “Offers”) to purchase for cash up to C$400,000,000 (the “Maximum Purchase Amount”) in aggregate purchase price, excluding accrued and unpaid interest, of its outstanding senior notes of each series listed in the table below (collectively, the “Notes”), which Maximum Purchase Amount may be increased, decreased or waived by the Company in its sole discretion. Each Offer is subject to the satisfaction or waiver of certain conditions. The Offers The Offers are made upon the terms and subject to the conditions set forth in the offer to purchase dated July 11, 2025 relating to the Notes (the “Offer to Purchase”). Capitalized terms used but not defined...

Continue reading

BriaCell’s Bria-IMT™ Demonstrates Survival Advantage over Trodelvy® and Control Group in Metastatic Breast Cancer

Median Overall Survival (OS) of 13.9 months in triple negative breast cancer (TNBC) exceeds Trodelvy (11.8 months) and doubles control (6.9 months) OS of 17.3 months in HR+ metastatic breast cancer surpasses Trodelvy (14.4 months) and control (11.2 months) No treatment related discontinuations reportedPHILADELPHIA and VANCOUVER, British Columbia, July 11, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced updated Phase 2 survival data for its lead immunotherapy candidate, Bria-IMT, in combination with an immune check point inhibitor (CPI). The data show a meaningful survival advantage in heavily pretreated metastatic breast cancer (MBC) patient...

Continue reading

WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY (a public company incorporated with limited liability in Ireland) WISDOMTREE Brent Crude Oil 3X Daily Short SECURITIES ISIN: IE00BLRPRK35

11 July 2025 LEI: 2138003QW2ZAYZODBU23 LSE Code: 3BRS WISDOMTREE MULTI ASSET ISSUER PUBLIC LIMITED COMPANY(a public company incorporated with limited liability in Ireland)WISDOMTREE Brent Crude Oil 3X Daily Short SECURITIESISIN: IE00BLRPRK35 PROPOSED AMENDMENT TO THE PRINCIPAL AMOUNT OF THE AFFECTED SECURITIES ADJOURNMENT OF MEETING OF THE ETP SECURITYHOLDERS THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt about what action you should take, you are recommended to consult your independent financial adviser. If you have sold or transferred all of your WisdomTree Brent Crude Oil 3X Daily Short Securities (the “Affected Securities”) of WisdomTree Multi Asset Issuer Public Limited Company (the “Issuer”), please send this document, together with the accompanying form of proxy, at once to the purchaser...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.